![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07H 1/00 | |
C12N 1/20 | |||
C07H 19/16 | |||
C07H 19/14 | |||
C07H 19/23 | |||
A61K 38/44 | |||
C07D 307/33 | |||
A61P 31/18 |
(11) | Patento numeris | 3352781 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16849385.6 |
Europos patento paraiškos padavimo data | 2016-09-19 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/052409 |
Data | 2016-09-19 |
(87) | Numeris | WO 2017/053216 |
Data | 2017-03-30 |
(30) | Numeris | Data | Šalis |
201562222304 P | 2015-09-23 | US | |
201662302452 P | 2016-03-02 | US |
(72) |
GIRIJAVALLABHAN, Vinay, M., US
MCLAUGHLIN, Mark, US
CLEATOR, Edward, GB
KONG, Jongrock, US
GIBSON, Andrew William, GB
LIEBERMAN, David, R., GB
DIEGUEZ VAZQUEZ, Alejandro, GB
KEEN, Stephen Philip, GB
WILLIAMS, Michael, J., US
MOORE, Jeffrey, C., US
MILCZEK, Erika, M., US
PENG, Feng, US
BELYK, Kevin, M., US
SONG, Zhiguo Jake, US
|
(73) |
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US |
(54) | 4`-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF |
4`-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF |